socalTechnews
Home
Mobile
News and Events
  • Headlines
  • Events
  • Interviews
  • Jobs
  • Directory
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
    • About
  • Membership
  • About
  • Contact Us
    		•
    Search News
    Tuesday, May 6, 2008

    Apoptos Raises $28M
    San Diego-based Apoptos, a developer of oncology drugs, announced Tuesday that the company has raised $28M in funding. The firm said the Series A funding came in two tranches from Venrock, ARCH Venture Partners, Orbimed Advisors, and Advanced Technology Ventures. Apoptos is developing small molecule drugs for inducing tumor cell apoptosis--which will be applied to treating cancer. According to the firm, the funding will fund the company through 2010. The firm was founded by William H. Rastetter, Ph.D., who was previously Exec Chairman of Biogen Idec and is a partner at Venrock.
    posted on Tuesday, May 6, 2008 (Link to more information)

    Related companies:
    Apoptos

    Related stories:
    > inQ Raises $4.5M
    > Oluma Raises $9M
    > Telepacific Communications Raises $12M
    > StrongMail Raises $6M
    > LightPointe Raises $17M

    RSS Feed
    subscri be via emailNewsletter


    Previous news:

     Friday, July 25, 2008
    Thursday, July 24, 2008
    Wednesday, July 23, 2008
    Tuesday, July 22, 2008
    Monday, July 21, 2008